Full profile

Also known asCholecalciferol
Best forFoundational nutritional support · Correcting or preventing low vitamin D status · Northern-latitude, low-sun populations
Evidence gradeGrade C · Limited: early or small human trials
Studied dose range1,000–2,000 IU (25–50 mcg) daily for maintenance; up to the 4,000 IU (100 mcg) adult upper limit under guidance. Canadian non-prescription monograph routes cap lower; see label tips.
Time to effectNot acute; serum levels rise over roughly 6–12 weeks of daily use.
Best formD3 (cholecalciferol) over D2; take with a fat-containing meal for absorption.
Food sourcesFatty fish (salmon, mackerel, sardines), Cod liver oil, Egg yolks, UV-exposed mushrooms, Fortified milk and plant milks

Evidence, honestly graded

For its own roles (bone, calcium, immune) the evidence is strong, but for cognition specifically it is weak: a 24-trial meta-analysis found only a small global-cognition effect concentrated in deficient groups, and RCTs in replete healthy adults show no cognitive benefit. Graded C for the cognition angle only.

See the full grading rubric (study type, replication, population match, and dose adequacy) in The Evidence Standard.

316 natural health products with an active licence in Health Canada's LNHPD list Vitamin D3 as a medicinal ingredient.

That makes Vitamin D3 a recognized, licensable medicinal ingredient in Canada, regulated by Health Canada's Natural and Non-prescription Health Products Directorate, which issues each licensed natural health product a Natural Product Number (NPN). Search the LNHPD to verify.

Source: Health Canada Licensed Natural Health Products Database, snapshot 2026-09-28. A count of products with an active licence, not an endorsement of any health claim. This describes the ingredient's regulatory standing in Canada, not Signal State Core, which is a pre-launch concept and is not a licensed natural health product.

Side effects

  • Very well tolerated at supplemental doses
  • Toxicity is rare and only at chronic high intakes (hypercalcemia)

Who should avoid it or check first

  • Hypercalcemia, hyperparathyroidism, or sarcoidosis
  • Kidney stones or significant renal impairment
  • Known vitamin D hypersensitivity

Interactions

  • May interact with thiazide diuretics, high-dose calcium, and digoxin; discuss with a clinician

Stacks well with

Use caution stacking with

  • Avoid high combined doses with separate calcium supplements without review

What to look for on a label

  • State both IU and micrograms (e.g. "1,000 IU (25 mcg)") since labels increasingly lead with mcg.
  • Respect the 4,000 IU (100 mcg) adult upper limit and add a "do not exceed" statement.
  • D3 works alongside two cofactors worth knowing about: magnesium is required to activate vitamin D in the body, and vitamin K2 (MK-7) works downstream of D to help direct the calcium it helps you absorb toward bone rather than soft tissue. See the Vitamin K2 (MK-7) entry and "Vitamin D and K2" article for the full picture. K2 interacts with warfarin and other blood thinners, so that combination needs a clear label warning.

References

  • Chen 2024, Neuropsychology Review: meta-analysis (24 RCTs). Small global-cognition effect across 24 RCTs / 7,557 people, concentrated in deficient groups. PMID 37418225; doi:10.1007/s11065-023-09598-z. Educational, not a product claim.
  • Health Canada NNHPD Vitamin D monograph. Permits bone/immune/good-health claims, not cognition. webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/1175. Confirm current version (NHP monographs updated effective 2026-03-27) before filing.

Entries above without a linked identifier are either editorial summaries of a wider body of literature or references to a named authority (a regulator or government monograph) cited by name rather than by a single paper.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

Revision history

Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.

  • 2026-07-08New profile

    Initial profile published at Grade C for cognition specifically: a 24-trial meta-analysis found only a small effect concentrated in deficient groups, with no cognitive lift in replete adults; its bone, calcium, and immune roles grade stronger separately.

See how Vitamin D3 compares on grade, dose, and goal in the Evidence Explorer.